tiprankstipranks
Blurbs

LifeSci Capital Reaffirms Their Buy Rating on Akili (AKLI)

LifeSci Capital analyst Rahul Rakhit maintained a Buy rating on Akili (AKLIResearch Report) today and set a price target of $1.48. The company’s shares closed today at $1.48.

According to TipRanks, Rakhit is ranked #8156 out of 8199 analysts.

Akili has an analyst consensus of Moderate Buy, with a price target consensus of $2.37, representing a 60.14% upside. In a report released yesterday, Credit Suisse also maintained a Buy rating on the stock with a $4.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $37.58 and a one-year low of $0.86. Currently, Akili has an average volume of 176.3K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Social Capital Suvretta Holdings Corp I is a blank check company.

Read More on AKLI:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles